epigallocatechin gallate has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Li, WJ; Liu, X; Shi, ZW; Wang, LF; Xie, MY; Yan, YX; Yao, YF | 1 |
| Stammler, G; Volm, M | 1 |
2 other study(ies) available for epigallocatechin gallate and Sarcoma 180
| Article | Year |
|---|---|
(-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Calcium; Cardiotonic Agents; Cardiotoxicity; Catechin; Doxorubicin; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Mice; Microscopy, Electron, Transmission; Myocytes, Cardiac; Reactive Oxygen Species; Sarcoma 180; Superoxide Dismutase; Tea | 2017 |
Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Flavonoids; Humans; Mice; Sarcoma 180; Tea; Tumor Cells, Cultured | 1997 |